We standardize therapeutic cannabinoids derived from botanical matrices under a pharmaceutical approach: definition of specifications, analytical controls and acceptance criteria aimed at ensuring batch-to-batch consistency and suitability for clinical use.
We design the quality program to support clinical use: quality controls, stability studies and documentary traceability aligned with European regulatory expectations for active substances and medicinal products.
We convert botanical extracts into a single-dose pharmaceutical form with a design oriented toward reproducible dosing, controlled performance and industrial feasibility, facilitating clinical development programs under pharmaceutical standards.
Medical Flowers Developments collaborates with pharmaceutical and biotech companies interested in cannabinoid clinical trials. The company maintains an open approach to professional discussions focused on development, innovation, and investment in regulated projects.
